Abstract
It is estimated1 that 179,000 women in the United States will be diagnosed with breast cancer in 1998 and that 44,000 will die from it. About one in eight women will develop breast cancer sometime in her life.2 Many women are therefore concerned about the risk of developing breast cancer, especially women with known risk factors such as a history of breast cancer in close relatives. The purpose of this paper is to review and compare two models for projecting the individualized risk of developing breast cancer over defined age ranges. One model,3 based on data from the Breast Cancer Detection Demonstration Project (BCDDP), uses information on family history, age at menarche, age at first live birth, number of biopsies, and the presence of atypical hyperplasia. A second model by Claus, Risch, and Thompson,4 which we refer to as the “Claus model”, relies on detailed family history information, including age at breast cancer onset in affected relatives. Published tables5 based on that model cover individuals with at least one affected relative.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Landis SH, Murray T, Bolden S, et al: Cancer Statistics, 1998. CA-A Cancer Journal for Clinicians 48:6–29, 1998
Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973–1994 Bethesda, MD, National Cancer Institute, NIH Pub. No. 97-2789, page 131, 1997
Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886, 1989
Claus EB, Risen NJ, Thompson WD: Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232–242, 1991
Claus EB, Risen N, Thompson WD: Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer 73:643–651, 1994
Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408, 1997
Whittemore AS, Gong G, Itnyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60:496–504, 1997
Benichou J, Gail MH, Mulvihill JJ: Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 14:103–110, 1996
Benichou J: A computer program for estimating individualized probabilities of breast cancer. Comput Biomed Res 26:373–382, 1993
Benichou J, Gail MH: Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 51:182–194, 1995
Benichou J: A complete analysis of variability for estimates of absolute risk from a population-based case-control study on breast cancer. Biometric J 37:3–24, 1995
Gail MH, Benichou J: Assessing the risk of breast cancer in individuals, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Prevention. Philadelphia, PA, Lippincott, pp 1–15, 1992
Spiegelman D, Colditz GA, Hunter D, et al: Validation of the Gail et al. model for predicting individualized breast cancer risk. J Natl Cancer Inst 86:600–607, 1994
Bondy ML, Lustbader ED, Halabi S, et al: Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86:600–607, 1994
Redmond CK, Costantino JP: Design and current status of the NSABP breast cancer prevention trial,in Senn HJ, Gelber RD, Goldhirsch A, Thurlimann B (eds): Recent Results in Cancer Research 140: Adjuvant Therapy of Breast Cancer. Berlin, Springer-Verlag, pp 309–317, 1996
McGuigan KA, Ganz PA, Breant C: Agreement between breast cancer risk estimation methods. J Natl Cancer Inst 88:1315–1317, 1996
McTiernan A, Gilligan MA, Redmond C: Asessing individual risk for breast cancer: Risky business. J Clin Epidemiol 50:547–556, 1997
Ottman R, Pike MC, King MC, et al: Practical guide for estimating risk for familial breast cancer. Lancet ii:556–558, 1983
Anderson DE, Badzioch MD: Risk of familial breast cancer. Cancer 56:383–387, 1985
Taplin S, Thompson RS, Schnitzer F, et al: Revisions in the risk-based breast cancer screening program at Group Health Cooperative. Cancer 66:812–818, 1990
Ford D, Easton DF, Bishop DT, et al: Risk of cancer in BRCA-1 mutation carriers. Lancet 343:692–695, 1994
Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457–1462, 1995
Li F: Familial aggregation, in Schottenfeld D, Fraumeni JF, Jr (eds): Cancer Epidemiology and Prevention (ed 2). New York, Oxford University Press, pp 546–558, 1966
Hanssen AMN, Fryns JB: Cowden syndrome. J Med Genet 32:117–119, 1995
Berry DA, Parmigianni G, Sanchez J, Schildkraut J, Winer E: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227–228, 1997
Miller BA, Ries LAG, Hankey BF, et al: Cancer statistics review: 1973–1989. Natl Cancer Inst. NIH Publ. No. 92-2789, Washington, DC, US Government Printing Office, 1992
Kelsey JL: A review of the epidemiology of breast cancer. Epidemiol Rev 1:74–109, 1979
Harris JR, Lippman ME, Veronesi U, et al: Breast cancer. N Engl J Med 327:319–328, 1992
Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative disease. N Engl J Med 312:146–151, 1985
Carter CL, Corle DK, Micozzi MS, et al: A prospective study of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477, 1988
Byrne C, Schairer C, Wolfe J, et al: Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629, 1995
Gail MH, Benichou J: Validation studies on a model for breast cancer risk. J Natl Cancer Inst 86:573–575, 1994 (editorial)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gail, M.H., Benichou, J. (1999). Estimating Individualized Risk of Breast Cancer. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4699-3_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7128-1
Online ISBN: 978-1-4615-4699-3
eBook Packages: Springer Book Archive